Enrolment trends in a comprehensive HIV programme in rural north-central Nigeria: improved care indices, but declining quality of clinical data over time

References

• UNAIDS. Special report update: how Africa turned AIDS around. 2013. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130521_Update_Africa.pdf (accessed 2014 May 15).
   Google Scholar
• National Agency for the Control of AIDS (NACA). Federal Republic of Nigeria Global AIDS Response. Country Progress Report, Nigeria, GARPR 2012. Abuja, Nigeria. 2012. Available from: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/Nigeria%202012%20GARPR%20Report%20Revised.pdf.
   Google Scholar
• The U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Partnership Framework on HIV/AIDS, 2010–2015. A Memorandum of understanding between the Government of Nigeria and the United States Government to Fight HIV/AIDS in Nigeria. 2014. Available from: http://www.pepfar.gov/documents/organization/148812.pdf (accessed 2014 June 11).
   Google Scholar
• Measure DHS/ICF International. Nigeria demographic and health survey, 2013. Preliminary Report. Calverton, MD, USA: National Population Commission; 2013.
   Google Scholar
• Federal Ministry of Health, Nigeria (FMOH). National AIDS/STI Control Program. Technical Report 2010 National HIV Sero-prevalence Sentinel Survey. Abuja, Nigeria: Federal Ministry of Health; 2010. Available from: http://www.nigeriaaids.org/documents/2010_National%20HIV%20Sero%20Prevalence%20Sentinel%20Survey.pdf (accessed 2014 June 1).
   Google Scholar
• Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY, et al. Risk factors for delayed initiation of combination antiretroviral therapy in rural North Central Nigeria. J Acquir Immune Defic Syndr. 2014;65(2):e41–9.
   Web of Science ®Google Scholar
• Geng EH, Hunt PW, Diero LO, Kimaiyo S, Somi GR, Okong P, et al. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. J Int AIDS Soc. 2011;14:46.
   PubMedGoogle Scholar
• Federal Ministry of Health, Nigeria (FMOH). National guidelines for HIV and AIDS treatment and care in adolescents and adults. Abuja, Nigeria: Federal Ministry of Health; 2007.
   Google Scholar
• Abimiku AG. Institute of Human Virology, University of Maryland School of Medicine PEPFAR Program (AIDS Care Treatment in Nigeria [ACTION]). Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. Am J Clin Pathol. 2009;131(6):875–86.
   PubMed Web of Science ®Google Scholar
• Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, Giddy J, et al. International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010;24(14):2263–70.
   PubMedGoogle Scholar
• UNAIDS. Regional fact sheet 2012. 2014. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/2012_FS_regional_ssa_en.pdf (accessed 2014 June 11).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Differences between HIV-Infected men and women in antiretroviral therapy outcomes – six African countries, 2004-2012. Morb Mortal Wkly Rep. 2013;62(47):945–52.
   Web of Science ®Google Scholar
• Lahuerta M, Wu Y, Hoffman S, Elul B, Kulkarni SG, Remien RH, et al. Multi-level determinants of late ART initiation in sub-Saharan Africa Team and identifying optimal models of HIV Care in sub-Saharan Africa Collaboration. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries. Clin Infect Dis. 2014;58(3):432–41.
   PubMedGoogle Scholar
• Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, et al. International epidemiologic databases to evaluate AIDS Southern Africa Collaboration. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. PLoS Med. 2012;9(9):e1001304.
   Google Scholar
• Moon TD, Burlison JR, Blevins M, Shepherd BE, Baptista A, Sidat M, et al. Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from President's Emergency Plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS. 2011;22:621–7.
   PubMed Web of Science ®Google Scholar
• Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J. 2006;96(4):315–20.
   PubMed Web of Science ®Google Scholar
• Rich ML, Miller AC, Niyigena P, Franke MF, Niyonzima JB, Socci A, et al. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr. 2012;59(3):e35–e42.
   Web of Science ®Google Scholar
• Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, et al. Enhanced CD4+T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013;368(3):218–30.
   PubMed Web of Science ®Google Scholar
• Tucker JD, Bien CH, Easterbrook PJ, Doherty MC, Penazzato M, Vitoria M, et al. Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic review. AIDS. 2014;28(Suppl 2):S151–60.
   Google Scholar
• Sartorius BK, Chersich MF, Mwaura M, Meda N, Temmerman M, Newell ML, et al. Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries. BMC Infect Dis. 2013;13:522.
   PubMed Web of Science ®Google Scholar
• Parrish DD, Blevins M, Megazzini KM, Shepherd BE, Mohammed MY, Wester CW, et al. Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria. Int J STD AIDS. 2014;25(5):355–9.
   PubMed Web of Science ®Google Scholar
• Jani SitoeNE IV, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378:1572–9.
   PubMed Web of Science ®Google Scholar
• Aliyu MH, Blevins M, Audet C, Shepherd BE, Hassan A, Onwujekwe O, et al. Optimizing PMTCT service delivery in rural North-Central Nigeria: protocol and design for a cluster randomized study. Contemp Clin Trials. 2013;36(1):187–97.
   PubMed Web of Science ®Google Scholar